Prostate News Archive
31-Dec-2008
FDA approves first new drug for advanced prostate cancer in years (CancerFacts.com)
WASHINGTON, DC ? Dec. 29, 2008 ? The U.S. Food and Drug Administration has approved the injectable drug degarelix, the first new drug in several years for prostate cancer. GTx Submits New Drug Application for Toremifene 80 mg for the Prevention of Bone Fractures in Men with Prostate Cancer ... (Centre Daily Times)
GTx, Inc. (Nasdaq: GTXI) today announced the submission of a New Drug Application with the U.S. Food and Drug Administration (FDA) for toremifene 80 mg, an oral selective estrogen receptor modulator (SERM), for the prevention of bone fractures in men with prostate cancer on androgen deprivation therapy (ADT). FDA OKs Swiss drug for prostate cancer treatment (Chicago Tribune)
ProstateDrug-FDAAppro Federal regulators on Monday said they have approved the first new drug to treat prostate cancer in several years. Degarelix Approved for Advanced Prostate Cancer (MedicineNet.com)
Title: Degarelix Approved for Advanced prostate Cancer Category: Health News Created: 12/30/2008 2:00:00 AM Last Editorial Review: 12/30/2008
Back to Prostate News Archive
